Skip to main content
Diamines & Chemicals Ltd. logo

Diamines & Chemicals Ltd. — Investor Relations & Filings

Ticker · DIAMINESQ ISIN · INE591D01014 LEI · 335800AQNIZET87LXI95 BSE.NS Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2025-02-06 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS DIAMINESQ

About Diamines & Chemicals Ltd.

https://dacl.co.in/

Diamines & Chemicals Ltd. specializes in the production of ethylene amines and related chemical intermediates. The company’s core product portfolio includes Ethylenediamine (EDA), Diethylenetriamine (DETA), Triethylenetetramine (TETA), Tetraethylenepentamine (TEPA), and Piperazine. These specialty chemicals are utilized across diverse sectors, including pharmaceuticals, agrochemicals, polyamide resins, and water treatment. The firm operates integrated manufacturing facilities designed for the synthesis of high-purity organic compounds. By leveraging advanced chemical processes, it provides essential raw materials for applications in oilfield chemicals, textile auxiliaries, and paper chemicals. The organization maintains a focus on technical excellence and process innovation to meet the stringent requirements of global supply chains.

Recent filings

Filing Released Lang Actions
We Submit herewith Integrated (Finance) for the quarter ended 31.12.2024
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Integrated Filing (Financial) for the quarter ended December 31, 2024' and is submitted pursuant to SEBI circulars related to quarterly financial filings. It includes detailed information on the use of proceeds from a Qualified Institutions Placement, fund utilization, and other financial disclosures relevant to the quarter ending December 31, 2024. The document length is 5687 characters, which is sufficient to contain substantive financial data and analysis. It is not merely an announcement or a certification but contains actual financial information for a quarter. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2025
2025-02-06 English
Integrated Filing- Financial
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Integrated Filing (Financial) for the quarter ended December 31, 2024' and references SEBI circulars related to financial filings. It includes detailed information about a Qualified Institutions Placement (QIP), fund raising amount, utilization, and deviation statements. The document is 5687 characters long, which is sufficient to contain substantive financial data. It is not merely an announcement or a certification but contains actual financial and fund utilization details for a quarter. The content aligns with disclosures typically found in quarterly financial reports or integrated filings that include financial results and fund utilization. Therefore, the document fits best under the category of Interim / Quarterly Report (IR). Q3 2025
2025-02-06 English
Statement of deviation(s) or variation(s) under Reg. 32
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) disclosing information pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It specifically provides a "Statement of Deviation/ Variation in utilisation of funds raised" through a preferential issue for the quarter ended December 31, 2024. The content focuses on compliance disclosure about the use of funds raised, deviations, and related audit comments. It does not contain financial statements or detailed financial performance data, nor is it a full report. The document is regulatory in nature, fulfilling a mandatory disclosure requirement under SEBI regulations. It is not an annual or quarterly report, earnings release, or management discussion. It is also not a report publication announcement since it contains substantive disclosure information. Therefore, the best fitting category is Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-02-06 English
We submit herewith compliance under regulation 32 of SEBI (LODR) Regulations 2015
Regulatory Filings Classification · 95% confidence The document is a disclosure pursuant to Regulation 32(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically for the quarter ended December 31, 2024. It contains a statement of deviation or variation in the utilization of funds raised through a preferential issue. The content focuses on compliance and regulatory disclosure about fund usage rather than presenting full financial statements or detailed financial performance. The document length is about 4810 characters, which is relatively short and primarily serves as a regulatory compliance announcement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like Interim Report or Capital/Financing Update.
2025-02-06 English
Outcome of Board Meeting
Regulatory Filings
2025-02-06 English
We submit herewith Financial Results for the quarter and nine months ended 31.12.2024
Regulatory Filings
2025-02-06 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.